fda_approval · anda · info
I3 PHARMS — ANDA approval: EVEROLIMUS (unspecified)
- Event date
- 2026-06-30 00:00:00Z
- Observed
- 2026-07-09 22:53:24Z
- Source ID
- ANDA219464-1
- Payload hash
- 291f651575bcd0029fbc7b73…
Summary
I3 PHARMS received ANDA approval for EVEROLIMUS (unspecified) on 2026-06-30. Dosage form: TABLET. Application #: ANDA219464.
Entities
Informational only. Not legal, financial, or medical advice.